XFeet-Orthotics jumps feet-first into the 3D orthopedic insole market
With their mother a dancer at the Paris Opera, how could they not be aware of mechanical problems in people’s feet?
ID Solutions, a startup that became the master of detection kits for Covid-19 and variants
During the health crisis, the company applied its extensive expertise in PCR technology for cancer to help in the fight against the pandemic. This is known as successful diversification.
IMAIOS, inventing e-anatomy
Founded in 2008 by two radiologists, the Montpellier BIC graduate startup is listed in the 2021 ranking of France’s 500 growth champions. Here’s an x-ray of their success.
Ventum Biotech, anti-Covid disinfection
Founded in August 2019, the startup has undergone exponential growth since the health crisis began, in France and internationally, thanks to its innovative bactericide and virucide product.
Inovie reaffirms its presence in Montpellier
The medical biology group Inovie invests 12 M€ to centralize its headquarters, main technical platform, veterinary subsidiary Inovie Vet, and new Labosud logistics center on 11,200 m² in Montpellier.
Quantum Surgical plans to launch its liver cancer robot in 2021
Co-founded by Bertin Nahum, the company continues to hire while also preparing a round of investment totaling 40 M€. A new excellence cluster emerges in Montpellier.
With IRMB, tomorrow’s medicine is taking shape in the greater Montpellier area
The Institute of Regenerative Medicine and Biotherapies focuses on personalized reparative medicine, deploying innovative biotherapies based on stem cells. Know-how at research’s cutting edge.
IAGE sets up at Biopôle office center for life sciences
Specialized in environmental biological diagnostics, the startup was looking to expand its facilities to handle its growing business activity, in part boosted by the COVID-19 health crisis.
With Vik, Wefight helps sick people break out of their isolation
The startup created a virtual companion as a mobile application that improves the daily lives of patients with chronic diseases or cancer. Success has encouraged Wefight to expand its solution’s fe...
Phost’In, soon to be the European champion in invasive cancer treatment
After finalizing fundraising for 10.3 M€ in April and consolidating its scientific team, the Montpellier-based biotech company has just confirmed additional funding of 2.5 M€.